Autologue PAP-loaded dendritic cell vaccine (APC8015, Provenge) in patients with non-metastatic prostate cancer who experience PSA elevation following radical prostatectomy: A randomized, controlled, double-blind trial
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2006
At a glance
- Drugs Sipuleucel-T (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 09 Feb 2006 New trial record.